Betaine alleviates MASLD through hepatic N6-methyladenosine (m6A)-dependent translational regulation

Background N6-methyladenosine (m6A) methylation is emerging as a key regulator of mRNA translation, but its role in metabolic dysfunction-associated steatotic liver disease (MASLD) remains poorly understood. Whether betaine, a methyl donor, alleviates hepatic steatosis through m6A-mediated translational regulation has not been explored. Methods A high-fat diet (HFD)-induced MASLD mouse model, with or without betaine intervention, was analyzed using integrated multi-omics approaches, followed by in vitro validation. Results Betaine ameliorated HFD-induced hepatic steatosis and liver injury. Integrative analysis revealed betaine-induced alterations in m6A methylation, and genes bearing differential m6A peaks were enriched in lipid metabolism and autophagy pathways. Notably, m6A modifications, particularly in coding regions, were associated with enhanced translation of target genes. Protein-protein interaction (PPI) analysis highlighted ANKHD1 as a hub gene. In vitro , betaine reduced lipid accumulation and enhanced ANKHD1 translation, whereas ANKHD1 knockdown attenuated the lipid-lowering effect of betaine, suggesting a potential role for ANKHD1 in the hepatoprotective action of betaine. Conclusion This study provides a comprehensive characterization of m6A-mediated translational regulation in betaine-induced amelioration of hepatic steatosis. Our findings suggest that the m6A- ANKHD1 axis may contribute to betaine’s beneficial effects on MASLD, and identify ANKHD1 as a potential therapeutic target. These insights may inform nutritional strategies for improving hepatic lipid metabolism in livestock production.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-18
DOI
https://doi.org/10.3389/fphar.2026.1962619
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Betaine alleviates MASLD through hepatic N6-methyladenosine (m6A)-dependent translational regulation

Jingsu Yu, Wenqian Nong, Tengda Huang, Xiangling Li et al.
4 links
Frontiers in Pharmacology
RNA modifications and cancer
article

Betaine alleviates MASLD through hepatic N6-methyladenosine (m6A)-dependent translational regulation

Jingsu Yu, Wenqian Nong, Tengda Huang, Xiangling Li, Qiuchen Cheng, Zhaoxuan Ding, Zupeng Luo, Ke Zheng, Xue Liang, Yunxiao Liang, Yuehui Liang, Lin Yu, Haisen Song, Siqi Liu, Yinzheng Li, Lei Zhou, Yixing Li, Qingqing Huo, Min Zhao
article en

Abstract

Background N6-methyladenosine (m6A) methylation is emerging as a key regulator of mRNA translation, but its role in metabolic dysfunction-associated steatotic liver disease (MASLD) remains poorly understood. Whether betaine, a methyl donor, alleviates hepatic steatosis through m6A-mediated translational regulation has not been explored. Methods A high-fat diet (HFD)-induced MASLD mouse model, with or without betaine intervention, was analyzed using integrated multi-omics approaches, followed by in vitro validation. Results Betaine ameliorated HFD-induced hepatic steatosis and liver injury. Integrative analysis revealed betaine-induced alterations in m6A methylation, and genes bearing differential m6A peaks were enriched in lipid metabolism and autophagy pathways. Notably, m6A modifications, particularly in coding regions, were associated with enhanced translation of target genes. Protein-protein interaction (PPI) analysis highlighted ANKHD1 as a hub gene. In vitro , betaine reduced lipid accumulation and enhanced ANKHD1 translation, whereas ANKHD1 knockdown attenuated the lipid-lowering effect of betaine, suggesting a potential role for ANKHD1 in the hepatoprotective action of betaine. Conclusion This study provides a comprehensive characterization of m6A-mediated translational regulation in betaine-induced amelioration of hepatic steatosis. Our findings suggest that the m6A- ANKHD1 axis may contribute to betaine’s beneficial effects on MASLD, and identify ANKHD1 as a potential therapeutic target. These insights may inform nutritional strategies for improving hepatic lipid metabolism in livestock production.

Frontiers in PharmacologyVol. 17
Guangxi University (CN), The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
Good health and well-being
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon